Related Experiment Video

Updated: Jun 11, 2026

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

HCC develops even in the early stage of chronic liver disease in elderly patients with HCV infection

Akio Takata1, Ryoko Kuromatsu, Eiji Ando

  • 1Division of Gastro-enterology, Department of Medicine, Kurume University School of Medicine, Fukuoka 830-0011, Japan. oika@med.kurume-u.ac.jp

International Journal of Molecular Medicine
|July 3, 2010
PubMed

Insights

Elderly patients with hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC) show better liver function. This study compared liver function and background factors in HCC patients across different age groups.

Area of Science:

  • Hepatology
  • Oncology
  • Geriatrics

Background:

  • Increasing incidence of hepatocellular carcinoma (HCC) in elderly populations.
  • Hepatitis C virus (HCV) infection is a significant risk factor for HCC.
  • Need to understand age-related differences in HCC presentation and liver function.

Purpose of the Study:

  • To compare liver function and background factors of HCV-related HCC patients across different age generations.
  • To characterize HCV-related HCC in elderly patients.

Main Methods:

  • Retrospective analysis of 1096 patients diagnosed with HCV-related HCC between 1995 and 2006.
  • Patients were divided into four age groups: ≤54 (A), 55-64 (B), 65-74 (C), and ≥75 (D).
  • Comparison of liver function (Child-Pugh class, ALT, TB, PT-INR, Alb) and clinical characteristics among the groups.

Main Results:

  • The average age at diagnosis was 66.9 years.
  • The elderly group (D, ≥75 years) had a significantly higher rate of Child-Pugh class A patients.
  • The elderly group showed significantly lower ALT, TB, and PT-INR levels, and a significantly higher Alb level compared to younger groups.

Conclusions:

  • HCV-related HCC in the elderly develops on a background of chronic liver disease with milder inflammation and fibrosis.
  • Elderly patients with HCV-related HCC may present with preserved or better liver function compared to younger cohorts.
  • Age is an important factor influencing the clinical presentation and liver function in HCV-related HCC.

More Related Videos

Generation of Subcutaneous and Intrahepatic Human Hepatocellular Carcinoma Xenografts in Immunodeficient Mice10:35

Generation of Subcutaneous and Intrahepatic Human Hepatocellular Carcinoma Xenografts in Immunodeficient Mice

Published on: September 25, 2013

Related Concept Videos

Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...